Our healthcare team has more than 40 years of combined experience of representing companies involved in drug discovery, development and commercialisation, manufacturing and healthcare services from around the world.
CLIENTS
MALIN
financial and corporate PR
UDG HEALTHCARE
Financial communications and M&A support for FTSE250 healthcare services company since 2012
SPYBIOTECH
Corporate and financial communications support for Oxford-based start-up, including launch of Covid-19 vaccine trial and Series A fundraising
ARIX BIOSCIENCE
Corporate and financial communications support for London-listed, global healthcare venture capital company
ACACIA RESEARCH
Communications advice, reputation and media relations management of life sciences investment portfolio
